Literature DB >> 27413019

Mitochondrial DNA disturbances and deregulated expression of oxidative phosphorylation and mitochondrial fusion proteins in sporadic inclusion body myositis.

Marc Catalán-García1, Glòria Garrabou2, Constanza Morén1, Mariona Guitart-Mampel1, Adriana Hernando1, Àngels Díaz-Ramos3, Ingrid González-Casacuberta1, Diana-Luz Juárez1, Maria Bañó1, Jennifer Enrich-Bengoa1, Sonia Emperador4, José César Milisenda1, Pedro Moreno1, Ester Tobías1, Antonio Zorzano3, Julio Montoya4, Francesc Cardellach1, Josep Maria Grau1.   

Abstract

Sporadic inclusion body myositis (sIBM) is one of the most common myopathies in elderly people. Mitochondrial abnormalities at the histological level are present in these patients. We hypothesize that mitochondrial dysfunction may play a role in disease aetiology. We took the following measurements of muscle and peripheral blood mononuclear cells (PBMCs) from 30 sIBM patients and 38 age- and gender-paired controls: mitochondrial DNA (mtDNA) deletions, amount of mtDNA and mtRNA, mitochondrial protein synthesis, mitochondrial respiratory chain (MRC) complex I and IV enzymatic activity, mitochondrial mass, oxidative stress and mitochondrial dynamics (mitofusin 2 and optic atrophy 1 levels). Depletion of mtDNA was present in muscle from sIBM patients and PBMCs showed deregulated expression of mitochondrial proteins in oxidative phosphorylation. MRC complex IV/citrate synthase activity was significantly decreased in both tissues and mitochondrial dynamics were affected in muscle. Depletion of mtDNA was significantly more severe in patients with mtDNA deletions, which also presented deregulation of mitochondrial fusion proteins. Imbalance in mitochondrial dynamics in muscle was associated with increased mitochondrial genetic disturbances (both depletion and deletions), demonstrating that proper mitochondrial turnover is essential for mitochondrial homoeostasis and muscle function in these patients.
© 2016 The Author(s). published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  OPA1; deletions; depletion; mitochondria; mitofusin-2; sporadic inclusion body myositis

Mesh:

Substances:

Year:  2016        PMID: 27413019     DOI: 10.1042/CS20160080

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  13 in total

Review 1.  Inclusion Body Myositis: Update on Pathogenesis and Treatment.

Authors:  Elie Naddaf; Richard J Barohn; Mazen M Dimachkie
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

Review 2.  Risk factors and disease mechanisms in myositis.

Authors:  Frederick W Miller; Janine A Lamb; Jens Schmidt; Kanneboyina Nagaraju
Journal:  Nat Rev Rheumatol       Date:  2018-04-20       Impact factor: 20.543

Review 3.  Genetics in inclusion body myositis.

Authors:  Simon Rothwell; James B Lilleker; Janine A Lamb
Journal:  Curr Opin Rheumatol       Date:  2017-11       Impact factor: 5.006

4.  Exhaustion of mitochondrial and autophagic reserve may contribute to the development of LRRK2 G2019S -Parkinson's disease.

Authors:  Diana Luz Juárez-Flores; Ingrid González-Casacuberta; Mario Ezquerra; María Bañó; Francesc Carmona-Pontaque; Marc Catalán-García; Mariona Guitart-Mampel; Juan José Rivero; Ester Tobias; Jose Cesar Milisenda; Eduard Tolosa; Maria Jose Marti; Ruben Fernández-Santiago; Francesc Cardellach; Constanza Morén; Glòria Garrabou
Journal:  J Transl Med       Date:  2018-06-08       Impact factor: 5.531

5.  Mitochondrial and autophagic alterations in skin fibroblasts from Parkinson disease patients with Parkin mutations.

Authors:  Ingrid González-Casacuberta; Diana-Luz Juárez-Flores; Mario Ezquerra; Raquel Fucho; Marc Catalán-García; Mariona Guitart-Mampel; Ester Tobías; Carmen García-Ruiz; José Carlos Fernández-Checa; Eduard Tolosa; María-José Martí; Josep Maria Grau; Rubén Fernández-Santiago; Francesc Cardellach; Constanza Morén; Glòria Garrabou
Journal:  Aging (Albany NY)       Date:  2019-06-09       Impact factor: 5.682

Review 6.  Sporadic Inclusion Body Myositis: An Acquired Mitochondrial Disease with Extras.

Authors:  Boel De Paepe
Journal:  Biomolecules       Date:  2019-01-07

7.  Mitochondrial implications in human pregnancies with intrauterine growth restriction and associated cardiac remodelling.

Authors:  Mariona Guitart-Mampel; Diana L Juarez-Flores; Lina Youssef; Constanza Moren; Laura Garcia-Otero; Vicente Roca-Agujetas; Marc Catalan-Garcia; Ingrid Gonzalez-Casacuberta; Ester Tobias; José C Milisenda; Josep M Grau; Fàtima Crispi; Eduard Gratacos; Francesc Cardellach; Glòria Garrabou
Journal:  J Cell Mol Med       Date:  2019-04-02       Impact factor: 5.310

8.  Mitochondrial Toxicogenomics for Antiretroviral Management: HIV Post-exposure Prophylaxis in Uninfected Patients.

Authors:  Maria Bañó; Constanza Morén; Sergio Barroso; Diana Luz Juárez; Mariona Guitart-Mampel; Ingrid González-Casacuberta; Judith Canto-Santos; Ester Lozano; Agathe León; Enric Pedrol; Òscar Miró; Ester Tobías; Josep Mallolas; Jhon F Rojas; Francesc Cardellach; Esteban Martínez; Gloria Garrabou
Journal:  Front Genet       Date:  2020-05-26       Impact factor: 4.599

Review 9.  Mitophagy and the Brain.

Authors:  Natalie S Swerdlow; Heather M Wilkins
Journal:  Int J Mol Sci       Date:  2020-12-18       Impact factor: 5.923

10.  Mitochondrial Dysfunction: A Common Hallmark Underlying Comorbidity between sIBM and Other Degenerative and Age-Related Diseases.

Authors:  Marc Catalán-García; Francesc Josep García-García; Pedro J Moreno-Lozano; Gema Alcarraz-Vizán; Adrià Tort-Merino; José César Milisenda; Judith Cantó-Santos; Tamara Barcos-Rodríguez; Francesc Cardellach; Albert Lladó; Anna Novials; Glòria Garrabou; Josep M Grau-Junyent
Journal:  J Clin Med       Date:  2020-05-13       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.